| 25 May 2026 |
MT-1 |
9.3 |
5mg |
5.8mg |
+15.6% |
98.08% |
Lab G |
| 25 May 2026 |
Supertest 450 |
7.6 |
200mg/ml |
182.2mg/ml |
-8.9% |
96.55% |
Lab A |
| 25 May 2026 |
Test Enanthate |
5.6 |
300mg/ml |
315.3mg/ml |
+5.1% |
95.73% |
Lab C |
| 24 May 2026 |
ACE-031 |
8.3 |
30mg |
29.9mg |
-0.2% |
96.71% |
Lab F |
| 24 May 2026 |
ACE-031 |
6.4 |
5mg |
6.2mg |
+24.9% |
95.91% |
Lab B |
| 24 May 2026 |
AHK-CU |
4.7 |
20mg |
18.8mg |
-6.1% |
99.18% |
Lab A |
| 24 May 2026 |
Dianabol |
6.2 |
50mg |
48.0mg |
-4.0% |
98.31% |
Lab B |
| 24 May 2026 |
MOTS-C |
6.4 |
2mg |
2.5mg |
+24.2% |
95.62% |
Lab E |
| 24 May 2026 |
Test Enanthate |
8.4 |
200mg/ml |
245.6mg/ml |
+22.8% |
99.27% |
Lab D |
| 24 May 2026 |
Test Enanthate |
6.3 |
100mg/ml |
87.6mg/ml |
-12.4% |
96.12% |
Lab D |
| 24 May 2026 |
TriTren 225 |
4.0 |
100mg/ml |
88.3mg/ml |
-11.7% |
98.21% |
Lab D |
| 24 May 2026 |
BPC157 10mg + TB500 10mg Blend |
7.0 |
5mg |
5.2mg |
+4.0% |
98.25% |
Lab G |
| 24 May 2026 |
DNP |
7.5 |
50mg |
43.9mg |
-12.1% |
99.01% |
Lab F |
| 24 May 2026 |
EPO |
7.0 |
10mg |
9.1mg |
-9.4% |
95.90% |
Lab F |
| 24 May 2026 |
Humanin |
5.6 |
50mg |
62.1mg |
+24.2% |
98.90% |
Lab D |
| 24 May 2026 |
IGF-1 LR3 |
8.8 |
10mg |
10.2mg |
+1.8% |
98.56% |
Lab A |
| 24 May 2026 |
MK-677 (Ibutamoren) |
8.2 |
50mg |
52.2mg |
+4.4% |
96.97% |
Lab C |
| 24 May 2026 |
Selank 10mg + Semax 10mg Blend |
6.9 |
15mg |
17.5mg |
+16.4% |
95.75% |
Lab F |
| 24 May 2026 |
Stanozolol (Winstrol) Raw |
7.0 |
100g |
106.8g |
+6.8% |
96.95% |
Lab D |
| 24 May 2026 |
T3 (Liothyronine) |
7.9 |
20mg |
23.0mg |
+14.9% |
99.92% |
Lab B |
| 24 May 2026 |
BMK methyl glycidate CAS 80532-66-7 |
7.6 |
5g |
5.0g |
+0.4% |
98.28% |
Lab A |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.8 |
50mg |
44.2mg |
-11.7% |
99.47% |
Lab G |
| 24 May 2026 |
MOTS-C |
4.0 |
15mg |
14.1mg |
-6.2% |
99.46% |
Lab C |
| 24 May 2026 |
Oxytocin Acetate |
8.1 |
2mg |
1.9mg |
-3.5% |
95.66% |
Lab B |
| 24 May 2026 |
Salbutamol |
6.7 |
20mg |
19.1mg |
-4.7% |
97.21% |
Lab A |
| 24 May 2026 |
Stanozolol (Winstrol) Raw |
8.2 |
1g |
1.0g |
-1.3% |
98.20% |
Lab F |
| 24 May 2026 |
Test Enanthate |
4.0 |
200mg/ml |
191.5mg/ml |
-4.2% |
95.10% |
Lab G |
| 24 May 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
8.7 |
1g |
0.9g |
-5.8% |
99.84% |
Lab B |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
8.9 |
10mg |
9.8mg |
-2.1% |
96.51% |
Lab C |
| 24 May 2026 |
EPO |
4.0 |
15mg |
17.8mg |
+18.5% |
98.43% |
Lab B |
| 24 May 2026 |
T3 (Liothyronine) |
6.7 |
50mg |
58.2mg |
+16.4% |
98.23% |
Lab D |
| 24 May 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
7.0 |
10g |
9.3g |
-6.9% |
95.25% |
Lab B |
| 24 May 2026 |
ACE-031 |
9.0 |
15mg |
17.5mg |
+16.6% |
99.00% |
Lab G |
| 24 May 2026 |
Oxytocin Acetate |
8.4 |
10mg |
10.3mg |
+3.1% |
97.31% |
Lab G |
| 24 May 2026 |
Oxytocin Acetate |
5.8 |
10mg |
10.9mg |
+8.6% |
95.47% |
Lab C |
| 24 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.5 |
5g |
4.8g |
-4.6% |
99.14% |
Lab E |
| 24 May 2026 |
Selank 10mg + Semax 10mg Blend |
6.5 |
15mg |
13.4mg |
-10.6% |
97.72% |
Lab D |
| 24 May 2026 |
Vitamin B12 10mg/ml |
7.8 |
100mg/ml |
93.3mg/ml |
-6.7% |
96.87% |
Lab A |
| 23 May 2026 |
AHK-CU |
7.3 |
10mg |
10.8mg |
+8.2% |
95.46% |
Lab F |
| 23 May 2026 |
MK-677 (Ibutamoren) |
10.0 |
25mg |
28.4mg |
+13.5% |
97.67% |
Lab B |
| 23 May 2026 |
MK-677 (Ibutamoren) |
10.0 |
10mg |
10.5mg |
+5.3% |
96.28% |
Lab B |
| 23 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.6 |
10g |
11.9g |
+19.1% |
98.63% |
Lab F |
| 23 May 2026 |
Winstrol (Stanozolol) |
7.4 |
10mg |
10.2mg |
+2.2% |
95.74% |
Lab G |
| 23 May 2026 |
IGF-1 LR3 |
8.7 |
30mg |
30.7mg |
+2.3% |
98.98% |
Lab B |
| 23 May 2026 |
Selank 10mg + Semax 10mg Blend |
6.4 |
20mg |
17.7mg |
-11.4% |
96.67% |
Lab A |
| 23 May 2026 |
Selank 10mg + Semax 10mg Blend |
4.0 |
30mg |
36.9mg |
+22.9% |
96.32% |
Lab C |
| 23 May 2026 |
Telmisartan |
8.4 |
25mg |
22.7mg |
-9.3% |
97.44% |
Lab B |
| 23 May 2026 |
Vitamin B12 10mg/ml |
7.5 |
300mg/ml |
316.8mg/ml |
+5.6% |
96.78% |
Lab F |
| 21 May 2026 |
Alprostadil |
6.2 |
2mg |
2.5mg |
+24.9% |
98.74% |
Lab E |
| 21 May 2026 |
Anadrol (Oxymetholone) |
5.1 |
10mg |
9.2mg |
-7.7% |
99.34% |
Lab A |
| 21 May 2026 |
Anadrol (Oxymetholone) |
8.6 |
50mg |
59.7mg |
+19.5% |
99.11% |
Lab C |
| 21 May 2026 |
BMK methyl glycidate CAS 80532-66-7 |
7.3 |
100g |
87.1g |
-12.9% |
95.97% |
Lab E |
| 21 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.4 |
15mg |
18.3mg |
+21.7% |
95.08% |
Lab F |
| 21 May 2026 |
IGF-1 LR3 |
5.6 |
10mg |
11.4mg |
+14.4% |
95.46% |
Lab B |
| 21 May 2026 |
Oxytocin Acetate |
8.1 |
50mg |
43.8mg |
-12.3% |
96.49% |
Lab E |
| 21 May 2026 |
Stanozolol (Winstrol) Raw |
9.0 |
500g |
508.5g |
+1.7% |
97.64% |
Lab A |
| 21 May 2026 |
Test Enanthate |
5.3 |
300mg/ml |
338.5mg/ml |
+12.8% |
99.78% |
Lab C |
| 21 May 2026 |
Tren Hex Raw |
6.7 |
10g |
9.3g |
-7.3% |
98.05% |
Lab E |
| 21 May 2026 |
BAM15 |
8.3 |
20mg |
20.5mg |
+2.7% |
95.73% |
Lab E |
| 21 May 2026 |
Lipo-B 216mg |
7.2 |
250mg/ml |
227.9mg/ml |
-8.8% |
99.40% |
Lab A |
| 21 May 2026 |
Minoxidil Oral |
8.7 |
25mg |
28.6mg |
+14.3% |
97.14% |
Lab C |
| 21 May 2026 |
Romosozumab |
6.3 |
30mg |
35.1mg |
+17.0% |
99.84% |
Lab B |
| 21 May 2026 |
Supertest 450 |
4.8 |
250mg/ml |
298.2mg/ml |
+19.3% |
96.49% |
Lab C |
| 20 May 2026 |
ACE-031 |
7.9 |
10mg |
11.3mg |
+12.8% |
97.61% |
Lab C |
| 20 May 2026 |
BMK methyl glycidate CAS 80532-66-7 |
5.0 |
1g |
1.2g |
+15.5% |
95.14% |
Lab B |
| 20 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
9.1 |
5mg |
4.3mg |
-14.4% |
96.35% |
Lab G |
| 20 May 2026 |
Minoxidil Oral |
7.3 |
25mg |
27.2mg |
+8.7% |
95.66% |
Lab D |
| 20 May 2026 |
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 |
7.1 |
5g |
4.5g |
-9.9% |
97.99% |
Lab F |
| 19 May 2026 |
Alprostadil |
7.2 |
50mg |
60.1mg |
+20.3% |
96.83% |
Lab G |
| 19 May 2026 |
Alprostadil |
7.7 |
10mg |
9.1mg |
-9.5% |
96.51% |
Lab E |
| 19 May 2026 |
Anadrol (Oxymetholone) |
6.6 |
50mg |
55.1mg |
+10.2% |
96.93% |
Lab B |
| 19 May 2026 |
DSIP |
7.4 |
5mg |
5.6mg |
+12.1% |
98.48% |
Lab A |
| 19 May 2026 |
Humanin |
6.9 |
50mg |
55.4mg |
+10.9% |
97.79% |
Lab A |
| 19 May 2026 |
Minoxidil Oral |
6.3 |
10mg |
12.0mg |
+20.1% |
98.12% |
Lab C |
| 19 May 2026 |
Minoxidil Oral |
8.8 |
10mg |
9.1mg |
-8.5% |
99.48% |
Lab G |
| 19 May 2026 |
Vitamin B12 10mg/ml |
7.8 |
300mg/ml |
331.5mg/ml |
+10.5% |
99.27% |
Lab C |
| 17 May 2026 |
IGF-1 LR3 |
5.6 |
50mg |
52.3mg |
+4.6% |
99.58% |
Lab A |
| 17 May 2026 |
KPV |
9.9 |
50mg |
57.3mg |
+14.6% |
95.87% |
Lab D |
| 17 May 2026 |
Supertest 450 |
6.5 |
250mg/ml |
253.8mg/ml |
+1.5% |
97.04% |
Lab B |
| 29 Jan 2026 |
Anadrol (Oxymetholone) |
6.9 |
25mg |
29.9mg |
+19.7% |
95.35% |
Lab C |
| 29 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.0 |
2mg |
2.3mg |
+14.8% |
95.75% |
Lab E |
| 29 Jan 2026 |
Dianabol |
8.9 |
10mg |
8.6mg |
-14.3% |
97.65% |
Lab D |
| 29 Jan 2026 |
HCG |
6.5 |
5mg |
4.9mg |
-2.9% |
95.79% |
Lab G |
| 29 Jan 2026 |
KPV |
7.6 |
50mg |
61.3mg |
+22.6% |
99.90% |
Lab E |
| 29 Jan 2026 |
Prostamax |
9.6 |
30mg |
34.1mg |
+13.7% |
96.93% |
Lab A |
| 29 Jan 2026 |
Romosozumab |
4.0 |
5mg |
5.4mg |
+8.8% |
99.81% |
Lab B |
| 29 Jan 2026 |
Selank 10mg + Semax 10mg Blend |
6.4 |
20mg |
17.6mg |
-12.2% |
99.40% |
Lab B |
| 29 Jan 2026 |
SNAP-8 |
6.3 |
2mg |
2.3mg |
+14.7% |
98.38% |
Lab F |
| 29 Jan 2026 |
Telmisartan |
6.5 |
10mg |
10.3mg |
+2.8% |
97.07% |
Lab B |
| 29 Jan 2026 |
Vitamin B12 10mg/ml |
8.7 |
200mg/ml |
229.8mg/ml |
+14.9% |
96.98% |
Lab D |
| 26 Jan 2026 |
Alprostadil |
8.0 |
50mg |
42.8mg |
-14.4% |
96.31% |
Lab B |
| 26 Jan 2026 |
BMK methyl glycidate CAS 80532-66-7 |
4.1 |
1g |
1.2g |
+20.4% |
95.84% |
Lab E |
| 26 Jan 2026 |
HGH Fragment 176-191 |
9.4 |
30mg |
28.7mg |
-4.5% |
98.82% |
Lab A |
| 26 Jan 2026 |
Romosozumab |
8.2 |
50mg |
55.3mg |
+10.5% |
96.04% |
Lab A |
| 26 Jan 2026 |
Supertest 450 |
7.4 |
300mg/ml |
366.0mg/ml |
+22.0% |
98.01% |
Lab G |
| 19 Jan 2026 |
Tirzepatide |
8.7 |
30mg |
(no batch claim) |
29mg |
-3.3% |
POL-T30-17 |
| 19 Jan 2026 |
ACE-031 |
5.0 |
20mg |
17.3mg |
-13.6% |
95.74% |
Lab C |
| 19 Jan 2026 |
HGH Fragment 176-191 |
6.8 |
2mg |
2.4mg |
+22.2% |
99.91% |
Lab D |
| 19 Jan 2026 |
Oxytocin Acetate |
9.1 |
2mg |
2.3mg |
+13.4% |
97.13% |
Lab E |
| 19 Jan 2026 |
Winstrol (Stanozolol) |
8.9 |
10mg |
10.5mg |
+5.4% |
97.69% |
Lab D |
| 9 Jan 2026 |
ACE-031 |
5.9 |
10mg |
9.5mg |
-4.9% |
99.42% |
Lab G |
| 9 Jan 2026 |
HCG |
5.8 |
5mg |
4.4mg |
-11.8% |
98.06% |
Lab C |
| 9 Jan 2026 |
IGF-1 LR3 |
6.6 |
15mg |
17.1mg |
+14.3% |
96.53% |
Lab E |
| 9 Jan 2026 |
Oxytocin Acetate |
7.6 |
50mg |
43.1mg |
-13.7% |
97.70% |
Lab D |
| 9 Jan 2026 |
Salbutamol |
6.3 |
20mg |
20.8mg |
+4.0% |
98.86% |
Lab F |
| 9 Jan 2026 |
Vitamin B12 10mg/ml |
7.5 |
200mg/ml |
222.3mg/ml |
+11.2% |
99.24% |
Lab C |
| 7 Jan 2026 |
Retatrutide |
7.5 |
10mg |
(no batch claim) |
10.4mg |
+4.0% |
(no batch ID) |
| 7 Jan 2026 |
ACE-031 |
8.7 |
5mg |
4.3mg |
-14.3% |
97.75% |
Lab D |
| 7 Jan 2026 |
Alprostadil |
6.4 |
10mg |
11.0mg |
+10.1% |
96.42% |
Lab D |
| 7 Jan 2026 |
Anadrol (Oxymetholone) |
5.9 |
20mg |
23.1mg |
+15.4% |
98.26% |
Lab C |
| 7 Jan 2026 |
BAM15 |
8.6 |
100mg |
99.1mg |
-0.9% |
97.26% |
Lab A |
| 7 Jan 2026 |
DSIP |
7.5 |
2mg |
2.3mg |
+15.7% |
98.81% |
Lab E |
| 7 Jan 2026 |
Selank 10mg + Semax 10mg Blend |
5.0 |
30mg |
28.2mg |
-6.1% |
97.20% |
Lab G |
| 7 Jan 2026 |
Stanozolol (Winstrol) Raw |
6.4 |
100g |
100.9g |
+0.9% |
99.31% |
Lab D |
| 7 Jan 2026 |
Telmisartan |
8.5 |
20mg |
20.9mg |
+4.6% |
96.29% |
Lab F |
| 7 Jan 2026 |
Vitamin B12 10mg/ml |
8.6 |
300mg/ml |
341.4mg/ml |
+13.8% |
99.38% |
Lab F |
| 6 Jan 2026 |
(2-Chloroethyl)benzene CAS 622-24-2 |
6.5 |
100g |
102.2g |
+2.2% |
96.62% |
Lab B |
| 6 Jan 2026 |
Anadrol (Oxymetholone) |
6.7 |
25mg |
30.1mg |
+20.2% |
96.08% |
Lab D |
| 6 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
7.5 |
5mg |
5.2mg |
+3.7% |
97.27% |
Lab A |
| 6 Jan 2026 |
MOTS-C |
8.7 |
10mg |
12.1mg |
+21.4% |
97.13% |
Lab D |
| 6 Jan 2026 |
Oxytocin Acetate |
7.3 |
30mg |
35.4mg |
+18.0% |
95.19% |
Lab E |
| 6 Jan 2026 |
Tren Hex Raw |
6.8 |
500g |
604.5g |
+20.9% |
97.48% |
Lab B |
| 6 Jan 2026 |
Winstrol (Stanozolol) |
7.3 |
25mg |
25.3mg |
+1.3% |
99.60% |
Lab B |
| 29 Dec 2025 |
(2-Chloroethyl)benzene CAS 622-24-2 |
6.2 |
10g |
10.0g |
+0.5% |
97.86% |
Lab B |
| 29 Dec 2025 |
(2-Chloroethyl)benzene CAS 622-24-2 |
7.2 |
5g |
4.4g |
-12.4% |
97.59% |
Lab D |
| 29 Dec 2025 |
BMK methyl glycidate CAS 80532-66-7 |
5.2 |
1g |
1.0g |
-4.4% |
98.00% |
Lab A |
| 29 Dec 2025 |
Dianabol |
6.0 |
100mg |
100.7mg |
+0.7% |
97.95% |
Lab C |
| 29 Dec 2025 |
DNP |
8.4 |
100mg |
111.2mg |
+11.2% |
95.31% |
Lab F |
| 29 Dec 2025 |
DNP |
6.1 |
50mg |
60.1mg |
+20.3% |
95.21% |
Lab B |
| 29 Dec 2025 |
DSIP |
7.7 |
20mg |
19.0mg |
-4.9% |
96.76% |
Lab D |
| 29 Dec 2025 |
Test Enanthate |
5.7 |
100mg/ml |
124.5mg/ml |
+24.5% |
97.19% |
Lab E |
| 29 Dec 2025 |
Test Enanthate |
9.3 |
250mg/ml |
269.2mg/ml |
+7.7% |
98.14% |
Lab C |
| 12 Dec 2025 |
BAM15 |
6.2 |
25mg |
23.1mg |
-7.7% |
98.18% |
Lab D |
| 12 Dec 2025 |
Dianabol |
6.3 |
100mg |
104.8mg |
+4.8% |
95.39% |
Lab A |
| 12 Dec 2025 |
DNP |
10.0 |
20mg |
18.0mg |
-9.9% |
99.53% |
Lab F |
| 12 Dec 2025 |
Selank 10mg + Semax 10mg Blend |
9.1 |
15mg |
13.4mg |
-10.9% |
96.05% |
Lab E |
| 5 Dec 2025 |
ACE-031 |
8.1 |
2mg |
2.1mg |
+5.9% |
97.13% |
Lab D |
| 5 Dec 2025 |
Anadrol (Oxymetholone) |
8.6 |
20mg |
23.6mg |
+17.9% |
97.12% |
Lab C |
| 5 Dec 2025 |
DNP |
6.8 |
50mg |
53.5mg |
+7.1% |
98.96% |
Lab G |
| 5 Dec 2025 |
IGF-1 LR3 |
7.0 |
15mg |
17.2mg |
+14.9% |
96.43% |
Lab B |
| 5 Dec 2025 |
MK-677 (Ibutamoren) |
9.6 |
100mg |
95.5mg |
-4.5% |
98.17% |
Lab F |
| 5 Dec 2025 |
Salbutamol |
7.0 |
10mg |
9.0mg |
-9.6% |
96.56% |
Lab B |
| 5 Dec 2025 |
Supertest 450 |
7.0 |
100mg/ml |
108.3mg/ml |
+8.3% |
99.01% |
Lab A |
| 25 Nov 2025 |
GHK-Cu |
8.4 |
50mg |
68.4mgwebsite |
73.1mg |
+6.9% |
POL-GC50-4 |
| 23 Nov 2025 |
(2-Chloroethyl)benzene CAS 622-24-2 |
8.2 |
1g |
1.0g |
+4.1% |
96.48% |
Lab C |
| 23 Nov 2025 |
Supertest 450 |
7.8 |
100mg/ml |
104.2mg/ml |
+4.2% |
95.45% |
Lab B |
| 23 Nov 2025 |
T3 (Liothyronine) |
6.1 |
50mg |
47.1mg |
-5.7% |
98.53% |
Lab C |
| 23 Nov 2025 |
Test Enanthate |
4.5 |
100mg/ml |
115.8mg/ml |
+15.8% |
99.69% |
Lab F |
| 17 Nov 2025 |
Anadrol (Oxymetholone) |
7.9 |
20mg |
23.2mg |
+16.0% |
96.67% |
Lab F |
| 17 Nov 2025 |
GHRP-2 Acetate |
10.0 |
50mg |
54.2mg |
+8.3% |
96.13% |
Lab B |
| 17 Nov 2025 |
GHRP-2 Acetate |
8.2 |
10mg |
11.2mg |
+11.6% |
96.01% |
Lab A |
| 17 Nov 2025 |
IGF-1 LR3 |
6.9 |
20mg |
23.0mg |
+15.2% |
98.53% |
Lab A |
| 17 Nov 2025 |
MOTS-C |
7.6 |
15mg |
14.6mg |
-2.6% |
95.35% |
Lab A |
| 14 Nov 2025 |
ACE-031 |
7.5 |
30mg |
32.8mg |
+9.3% |
96.17% |
Lab A |
| 14 Nov 2025 |
EPO |
4.8 |
10mg |
9.7mg |
-2.8% |
95.84% |
Lab B |
| 14 Nov 2025 |
KPV |
5.3 |
2mg |
2.3mg |
+13.3% |
99.66% |
Lab E |
| 14 Nov 2025 |
Telmisartan |
10.0 |
50mg |
61.0mg |
+22.0% |
99.50% |
Lab C |
| 7 Nov 2025 |
GHK-Cu |
9.0 |
50mg |
68.4mgwebsite |
69.35mg |
+1.4% |
POL-GC50-4 |
| 5 Nov 2025 |
DNP |
8.7 |
50mg |
47.2mg |
-5.6% |
96.21% |
Lab A |
| 5 Nov 2025 |
GHRP-2 Acetate |
7.8 |
5mg |
4.7mg |
-6.5% |
97.87% |
Lab A |
| 5 Nov 2025 |
Halotestin (Fluoxymesterone) |
9.6 |
25mg |
27.9mg |
+11.6% |
98.34% |
Lab C |
| 5 Nov 2025 |
Salbutamol |
7.9 |
100mg |
102.8mg |
+2.8% |
97.18% |
Lab D |
| 5 Nov 2025 |
Telmisartan |
6.8 |
20mg |
24.2mg |
+20.8% |
99.28% |
Lab B |
| 5 Nov 2025 |
Test Enanthate |
6.5 |
300mg/ml |
282.1mg/ml |
-6.0% |
97.67% |
Lab E |
| 4 Nov 2025 |
BMK methyl glycidate CAS 80532-66-7 |
7.2 |
100g |
98.0g |
-2.0% |
97.33% |
Lab C |
| 4 Nov 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.0 |
2mg |
2.2mg |
+9.7% |
97.31% |
Lab B |
| 4 Nov 2025 |
DSIP |
5.1 |
20mg |
18.5mg |
-7.7% |
96.97% |
Lab E |
| 4 Nov 2025 |
KPV |
6.8 |
5mg |
5.4mg |
+7.9% |
99.05% |
Lab E |
| 4 Nov 2025 |
KPV |
7.6 |
2mg |
2.0mg |
-0.0% |
99.06% |
Lab D |
| 4 Nov 2025 |
Oxytocin Acetate |
7.5 |
2mg |
1.7mg |
-15.0% |
95.17% |
Lab D |
| 4 Nov 2025 |
Telmisartan |
10.0 |
25mg |
22.9mg |
-8.3% |
96.69% |
Lab E |
| 4 Nov 2025 |
Winstrol (Stanozolol) |
7.1 |
20mg |
18.1mg |
-9.5% |
95.07% |
Lab C |
| 17 Oct 2025 |
BPC157 10mg + TB500 10mg Blend |
7.6 |
15mg |
13.9mg |
-7.1% |
98.29% |
Lab D |
| 17 Oct 2025 |
Dianabol |
8.7 |
20mg |
21.7mg |
+8.7% |
96.53% |
Lab G |
| 17 Oct 2025 |
KPV |
8.5 |
5mg |
4.9mg |
-2.6% |
97.58% |
Lab E |
| 17 Oct 2025 |
Romosozumab |
6.9 |
20mg |
24.0mg |
+20.1% |
95.31% |
Lab B |
| 17 Oct 2025 |
TriTren 225 |
4.6 |
300mg/ml |
322.0mg/ml |
+7.3% |
96.62% |
Lab G |
| 9 Oct 2025 |
Retatrutide |
7.7 |
5mg |
(no batch claim) |
4.53mg |
-9.4% |
520250728F |
| 9 Oct 2025 |
DNP |
6.7 |
20mg |
21.5mg |
+7.6% |
96.34% |
Lab C |
| 9 Oct 2025 |
Selank 10mg + Semax 10mg Blend |
7.0 |
50mg |
54.9mg |
+9.8% |
95.14% |
Lab F |
| 9 Oct 2025 |
Vitamin B12 10mg/ml |
9.1 |
100mg/ml |
112.9mg/ml |
+12.9% |
99.07% |
Lab F |
| 3 Oct 2025 |
Anadrol (Oxymetholone) |
6.4 |
50mg |
61.6mg |
+23.3% |
98.57% |
Lab C |
| 3 Oct 2025 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
9.5 |
30mg |
36.9mg |
+22.9% |
96.49% |
Lab D |
| 3 Oct 2025 |
HCG |
6.1 |
2mg |
1.9mg |
-6.6% |
96.14% |
Lab B |
| 3 Oct 2025 |
IGF-1 LR3 |
7.6 |
5mg |
4.7mg |
-6.5% |
97.25% |
Lab C |
| 3 Oct 2025 |
MOTS-C |
7.1 |
30mg |
30.0mg |
-0.1% |
99.41% |
Lab C |
| 1 Oct 2025 |
BPC-157 |
4.5 |
10mg |
11.4mgwebsite |
12.55mg |
+9.8% |
POL-BPC10-4 |
| 1 Oct 2025 |
BPC-157 |
6.0 |
5mg |
6.5mgwebsite |
6.14mg |
-5.7% |
POL-BPC5-2 |